Ceftazidime Panpharma

Ceftazidime Panpharma is an antibiotic medication used to treat bacterial infections. This broad-spectrum cephalosporin is effective against various gram-negative bacteria, including those resistant to other antibiotics.

Ceftazidime is primarily used to treat severe bacterial infections, including those affecting the lungs, urinary tract, and bloodstream. It is often prescribed for infections caused by gram-negative bacteria, which are resistant to other antibiotics. Ceftazidime is administered intravenously or intramuscularly, depending on the severity of the infection and the patient's condition.

Common effects of Ceftazidime may include mild to moderate pain at the injection site, nausea, diarrhea, and rash. Some patients may experience more severe reactions, such as allergic reactions or changes in blood cell counts. It is important to monitor for any adverse effects and consult a healthcare provider if they occur.

Ceftazidime should be used with caution in patients with a history of allergic reactions to cephalosporins or penicillin. It is important to inform your healthcare provider about any existing medical conditions or medications you are taking. Proper storage and handling of the medication are essential to maintain its effectiveness.

Ceftazidime may interact with certain medications, including other antibiotics, diuretics, and drugs that affect kidney function. It is important to discuss all current medications with your healthcare provider to avoid potential interactions. Alcohol should be avoided while taking Ceftazidime, as it may increase the risk of side effects.